Form 8-K - Current report:
SEC Accession No. 0001493152-25-018267
Filing Date
2025-10-16
Accepted
2025-10-16 09:15:51
Documents
16
Period of Report
2025-10-16
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K form8-k.htm   iXBRL 8-K 46018
2 EX-99.1 ex99-1.htm EX-99.1 15336
3 GRAPHIC ex99-1_001.jpg GRAPHIC 18196
4 GRAPHIC ex99-1_002.jpg GRAPHIC 9738
  Complete submission text file 0001493152-25-018267.txt   317317

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE biafw-20251016.xsd EX-101.SCH 3807
6 XBRL DEFINITION FILE biafw-20251016_def.xml EX-101.DEF 26632
7 XBRL LABEL FILE biafw-20251016_lab.xml EX-101.LAB 36635
8 XBRL PRESENTATION FILE biafw-20251016_pre.xml EX-101.PRE 25256
18 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 5821
Mailing Address 3300 NACOGDOCHES ROAD SUITE 216 SAN ANTONIO TX 78217
Business Address 3300 NACOGDOCHES ROAD SUITE 216 SAN ANTONIO TX 78217 210-698-5334
bioAffinity Technologies, Inc. (Filer) CIK: 0001712762 (see all company filings)

EIN.: 465211056 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41463 | Film No.: 251396603
SIC: 8731 Services-Commercial Physical & Biological Research
(CF Office: 08 Industrial Applications and Services)